Clinical Study to Evaluate Pharmacokinetic Profiles and Safety of CKD-387 Under Fasting Condition
Status:
Recruiting
Trial end date:
2023-02-18
Target enrollment:
Participant gender:
Summary
This study is a randomized, open-label, single dose, crossover study to evaluate the
pharmacokinetic profiles and safety of CKD-387 in healthy volunteers under fasting condition.